
zzso reduce cardiovascular morbidity and mortality from coronary artery disease zzso However, the effects of zzso therapy in patients with zzso and chronic kidney disease zzso remain zzso Within a single zzso cohort in the zzso Database zzso zzso all patients zzso zzso zzso who visited the zzso Institute, we followed patients with zzso and zzso after zzso coronary intervention zzso A major adverse cardiovascular and cerebrovascular event zzso was defined by composite end points, including death, zzso zzso cerebral zzso cerebral zzso and target zzso zzso A total of 391 patients were included in this study zzso follow-up time zzso zzso zzso zzso Of these, 209 patients used zzso Patients with zzso therapy were younger than those zzso zzso and zzso were more common, and the zzso zzso rate zzso was significantly higher, in patients undergoing zzso zzso zzso and cardiac death tended to be less common, and zzso death was significantly less common, in patients taking zzso zzso analysis showed that low estimated zzso poor left zzso ejection zzso and the absence of zzso therapy were independent zzso for zzso death of zzso patients after zzso zzso therapy was associated with reduced zzso mortality in patients with zzso and zzso after zzso 

